Cruger D G, Agerholm I, Byriel L, Fedder J, Bruun-Petersen G
Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.
Clin Genet. 2003 Sep;64(3):198-203. doi: 10.1034/j.1399-0004.2003.00128.x.
A total of 392 men referred for intracytoplasmic sperm injection (ICSI) participated in genetic analysis. The control group consisted of 100 normal fertile males. Chromosome and DNA analyses were performed to investigate the frequency of Y-chromosome microdeletions and CFTR mutations (the controls underwent DNA analysis only). An abnormal karyotype was found in 4.6% of all males, but the frequency among men with azoospermia was higher, at 11.7%. Y-chromosome microdeletions were found only among men with azoospermia (6.5%) and men with extreme oligospermia (2%). Compound heterozygosity for CFTR mutations was found in men with azoospermia (3.9%) and congenital bilateral absence of vas deferens (CBAVD) only. We conclude that all couples referred for ICSI should be offered chromosome analysis. DNA analysis for Y-chromosome microdeletions should be reserved for men with azoospermia or extreme oligospermia (<1 x 106 spermatozoa). Analysis for CFTR mutations should be limited to those with obstructive azoospermia or those with a family history of cystic fibrosis.
共有392名因接受卵胞浆内单精子注射(ICSI)而前来就诊的男性参与了基因分析。对照组由100名正常可育男性组成。进行了染色体和DNA分析,以研究Y染色体微缺失和囊性纤维化跨膜传导调节因子(CFTR)突变的频率(对照组仅进行了DNA分析)。在所有男性中,4.6%发现了异常核型,但无精子症男性中的频率更高,为11.7%。仅在无精子症男性(6.5%)和严重少精子症男性(2%)中发现了Y染色体微缺失。仅在无精子症男性(3.9%)和先天性双侧输精管缺如(CBAVD)男性中发现了CFTR突变的复合杂合性。我们得出结论,所有因ICSI前来就诊的夫妇都应接受染色体分析。Y染色体微缺失的DNA分析应仅用于无精子症或严重少精子症(<1×10⁶精子)的男性。CFTR突变分析应仅限于梗阻性无精子症患者或有囊性纤维化家族史的患者。